|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 221/16 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07F 9/40 | (2006.01) | ||
| A61K 31/435 | (2006.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 2880028 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13750427.0 |
| Date of filing the European patent application | 2013-07-31 | |
| (97) | Date of publication of the European application | 2015-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/052961 |
| Date | 2013-07-31 |
| (87) | Number | WO 2014/022528 |
| Date | 2014-02-06 |
| (30) | Number | Date | Country code |
| PCT/CN2012/0795 | 2012-08-02 | WO | |
| 201261696572 P | 2012-09-04 | US |
| (72) |
HAGMANN, William, K., US
NARGUND, Ravi, P., US
BLIZZARD, Timothy, A., US
JOSIEN, Hubert, US
BIJU, Purakkattle, US
PLUMMER, Christopher, W., US
DANG, Qun, US
LI, Bing, US
LIN, Linus, S., CN
CUI, Mingxiang, CN
HU, Bin, CN
HAO, Jinglai, CN
CHEN, Zhengxia, CN
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTIDIABETIC TRICYCLIC COMPOUNDS |
| ANTIDIABETIC TRICYCLIC COMPOUNDS |